🇺🇸 FDA
Patent

US 12083151

Synergistic bacterial compositions and methods of production and use thereof

granted A61KA61K31/00A61K35/74

Quick answer

US patent 12083151 (Synergistic bacterial compositions and methods of production and use thereof) held by Seres Therapeutics, Inc. expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Seres Therapeutics, Inc.
Grant date
Tue Sep 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/00, A61K35/74, A61K35/742, A61K35/744